Business Context and Reporting Period
Company: SANUWAVE Health, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 13, 2025
Reporting Period: Preliminary financial results for the quarter and year ended December 31, 2024.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. This 8-K serves as a notification that preliminary results have been issued via a press release (Exhibit 99.1), but the specific financial data points are not embedded in the body of this document.
Material Changes
The filing does not detail specific material changes versus prior periods. It references the issuance of a press release containing preliminary results for the period ended December 31, 2024, but does not summarize the variances within this text.
Guidance, Outlook, and Risks
Management Commentary: The Company issued a press release on January 13, 2025, announcing preliminary financial results.
Legal Disclaimer: The information in Item 2.02 and Exhibit 99.1 is furnished and not deemed "filed" under Section 18 of the Exchange Act. It is not subject to the liabilities of that section and shall not be deemed incorporated by reference in other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated January 13, 2025) for the actual numerical financial results.
- Verify the specific revenue and net income figures for the quarter and year ended December 31, 2024, as they are not listed in the 8-K summary text.
- Confirm if the preliminary results include any forward-looking guidance or updated risk factors.
- Note that the registrant is not currently listed on a specific exchange (Trading Symbol and Exchange Name listed as N/A).